CRISPR Therapeutics AG (CRSP)

CRISPR Therapeutics AG Revenue

CRISPR Therapeutics AG had revenue of $892.00K in the quarter ending June 30, 2025, with 72.53% growth. This brings the company's revenue in the last twelve months to $38.05M, down -81.18% year-over-year. In the year 2024, CRISPR Therapeutics AG had annual revenue of $37.31M, down -89.95%.

• Revenue (ttm): $38.05M
• Revenue Growth: -81.18%
• P/S Ratio: 158.52
• Revenue / Employee: $96,819
• Employees: 393
• Market Cap: 6.40B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	37.31M	-333.89M	-89.95%
Dec 31, 2023	371.21M	370.01M	30,885.48%
Dec 31, 2022	1.20M	-913.77M	-99.87%
Dec 31, 2021	914.96M	914.24M	127,154.94%
Dec 31, 2020	719.00K	-288.87M	-99.75%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.